Medication info
SOMDI Tablet

SOMDI Tablet

Prescription medicationTabletOral
Ingredient · strength
Raloxifene Hydrochloride›60mg / 1 tabletCholecalciferol Concentrate Powder›8mg / 1 tablet
Manufacturer / importer
Dongkwang Pharmaceutical Co., Ltd.
Appearance
Yellow round film-coated tablet
Packaging
30 tablets/box [(10 tablets/PTP) x 3]
Approval status
Active

MFDS item code 201707351 · Approved 2017.09.29 · Insurance code 645906330

Summary

Main use
Treatment and prevention of osteoporosis in postmenopausal women
Who takes it
Adults
Adult dose
Take this medicine if you require raloxifene therapy and have an inadequate intake of vitamin D. Take 1 tablet orally once daily.

Ingredients

Manufacturer
Dongkwang Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment and prevention of osteoporosis in postmenopausal women

  • Osteoporosis
View approved original text

Used for the treatment and prevention of osteoporosis in postmenopausal women.

How to take

Adult dose

Take this medicine if you require raloxifene therapy and have an inadequate intake of vitamin D. Take 1 tablet orally once daily.

Precautions

This medication may increase the risk of thrombus formation in the blood; therefore, it should be used with caution in patients with a history of thrombosis or those at high risk for thrombosis. In particular, if a state of immobility persists for a prolonged period, discontinuation of this medication should be considered, and it can be resumed after symptoms improve. Since this medication is primarily metabolized in the liver, it should not be administered to patients with poor liver function. The efficacy and safety of this medication have not been established in premenopausal women, and it should not be used in this population. It should not be used for the prevention of cardiovascular diseases and should be administered with caution to patients with a history or high risk of stroke. Women who are pregnant or breastfeeding should not use this drug, as it may harm the fetus or newborn. Patients with allergic reactions to this medication, liver disorders, unexplained uterine bleeding, or symptoms suggesting endometrial cancer should not use it. Caution is needed in patients with very high triglycerides, poor kidney function, and those with other specific diseases. During the use of this medication, symptoms such as leg cramps, facial flushing, cold symptoms, and peripheral edema may occur; if these symptoms are severe, consult a doctor. Caution is also required when this drug is taken with other medications, especially certain antacids, anticoagulants, and some antibiotics, and it should be taken according to a doctor's instructions. If there are plans for pregnancy or if pregnancy occurs during treatment, or if breastfeeding, this medication should not be taken, and if pregnancy is confirmed during use, the healthcare provider should be notified immediately. This medication should not be used in children or men, and should be used in the elderly with special caution. In case of overdose, symptoms such as dizziness, leg cramps, and vomiting may occur, requiring immediate assistance from healthcare providers. This medication should be stored out of reach of children and should not be transferred to another container.

Side effects

Vasodilation (flushing), deep venous thrombosis, pulmonary embolism, retinal vein thrombosis, superficial venous thrombophlebitis, leg cramps, cold symptoms, peripheral edema, slight decrease in platelet count, moderate elevation of AST and/or ALT, cholelithiasis, thrombocytopenia, nausea, vomiting, abdominal pain, dyspepsia, increased blood pressure, migraine, headache, rash, pain, mild breast symptoms such as enlargement and tenderness, arterial thromboembolism, retinal vein occlusion, stroke, death related to deep venous thrombosis, facial flushing, vaginal bleeding, facial swelling, heartburn, constipation, itching, palpitations, fever, lethargy, sweating, myalgia, insomnia, perineal pain, weight gain, arthritis, rheumatic-like pain, fatigue, tightness, chest pain, skin lesions, anxiety, weight loss, seizures, dyspnea, visual disturbances, taste disturbances, psychiatric symptoms, altered consciousness, headache, loss of appetite, weight loss, increased thirst, arrhythmia, increased urinary urgency, kidney stones, renal calcification, calcification in the outer tissue of bones, myalgia, arthralgia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius to ensure the effectiveness and safety of the drug.

Appearance and packaging

Appearance

Yellow round film-coated tablet

Package unit

30 tablets/box [(10 tablets/PTP) x 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.